Bioventus Past Earnings Performance
Past criteria checks 0/6
Bioventus's earnings have been declining at an average annual rate of -74.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 12.4% per year.
Key information
-74.8%
Earnings growth rate
-83.4%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 12.4% |
| Return on equity | -12.5% |
| Net Margin | -4.1% |
| Last Earnings Update | 30 Mar 2024 |
Recent past performance updates
Recent updates
Bioventus: Bullish On Path To Profitability
Jan 24Bioventus: Reiterating Buy Thesis Following Q2 Earnings
Sep 08Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M
Aug 11Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal
Aug 03Bioventus: Strong Value Gap, Insulated Via Leading Market Share
Jun 14Bioventus: Thoughts After An Active First Year
Mar 29Bioventus records first commercial shipment of BITS Balance system
Apr 27Revenue & Expenses BreakdownBeta
How Bioventus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Mar 24 | 523 | -22 | 301 | 12 |
| 31 Dec 23 | 512 | -97 | 304 | 13 |
| 30 Sep 23 | 503 | -159 | 303 | 18 |
| 01 Jul 23 | 511 | -224 | 313 | 20 |
| 01 Apr 23 | 514 | -227 | 327 | 23 |
| 31 Dec 22 | 512 | -104 | 332 | 24 |
| 01 Oct 22 | 517 | -91 | 336 | 25 |
| 02 Jul 22 | 497 | -19 | 326 | 27 |
| 02 Apr 22 | 466 | -16 | 306 | 25 |
| 31 Dec 21 | 431 | -5 | 254 | 19 |
| 02 Oct 21 | 399 | -3 | 235 | 15 |
| 03 Jul 21 | 376 | 6 | 216 | 12 |
| 03 Apr 21 | 324 | 4 | 187 | 10 |
| 31 Dec 20 | 321 | 16 | 193 | 11 |
| 26 Sep 20 | 320 | 16 | 185 | 11 |
| 27 Jun 20 | 316 | 12 | 180 | 11 |
| 28 Mar 20 | 339 | 15 | 189 | 11 |
| 31 Dec 19 | 340 | 9 | 198 | 11 |
| 31 Dec 18 | 319 | -1 | 192 | 8 |
| 02 Apr 16 | 266 | -23 | 151 | 15 |
| 31 Dec 15 | 254 | -38 | 148 | 15 |
| 31 Dec 14 | 243 | -17 | 146 | 9 |
| 31 Dec 13 | 232 | -26 | 146 | 11 |
Quality Earnings: BVS is currently unprofitable.
Growing Profit Margin: BVS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BVS is unprofitable, and losses have increased over the past 5 years at a rate of 74.8% per year.
Accelerating Growth: Unable to compare BVS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BVS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: BVS has a negative Return on Equity (-12.49%), as it is currently unprofitable.